3 days ago · Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

2 days ago · Zealand Pharma is listed on Nasdaq Copenhagen under the ticker symbol ZEAL. Access investor information including full share price in DKK plus investor tools. More Stock information

At Zealand Pharma, our research and development is directed at generating a pipeline of novel and differentiated peptide candidates.

Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

At Zealand Pharma, our research and development is directed at generating a pipeline of novel and differentiated peptide candidates.

Zealand Pharma Announces Financial Results for the First Nine Months of 2024. Continued strong progress across obesity pipeline with proprietary assets ready for Phase 2 backed by a solid financial position. • Presented extremely encouraging weight loss and tolerability data with long-acting amylin analog

Zealand Pharma is focused on disease areas where we believe peptide therapies can make a difference: obesity, rare diseases, chronic inflammation and type 1 diabetes

At Zealand Pharma, our research and development is directed at generating a pipeline of novel and differentiated peptide candidates.